Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
A randomised controlled trial to measure the effect of chest pain unit care upon anxiety, depression, and health-related quality of life [ISRCTN85078221].
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
- المؤلفون: Goodacre S;Goodacre S; Nicholl J
- المصدر:
Health and quality of life outcomes [Health Qual Life Outcomes] 2004 Jul 29; Vol. 2, pp. 39. Date of Electronic Publication: 2004 Jul 29.
- نوع النشر :
Clinical Trial; Journal Article; Randomized Controlled Trial
- اللغة:
English
- معلومة اضافية
- المصدر:
Publisher: BioMed Central Country of Publication: England NLM ID: 101153626 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7525 (Electronic) Linking ISSN: 14777525 NLM ISO Abbreviation: Health Qual Life Outcomes Subsets: MEDLINE
- بيانات النشر:
Original Publication: [London] : BioMed Central, c2003-
- الموضوع:
- نبذة مختصرة :
Background: The chest pain unit (CPU) has been developed to provide a rapid and accurate diagnostic assessment for patients attending hospital with acute, undifferentiated chest pain. We aimed to measure the effect of CPU assessment upon psychological symptoms and health-related quality of life.
Methods: We undertook a single-centre, cluster-randomised controlled trial. Days (N = 442) were randomised in equal numbers to CPU or routine care. Patients with acute chest pain, undiagnosed by clinical assessment, ECG and chest radiograph, were recruited and followed up with self-completed questionnaires (SF-36 and HADS) at two days and one month after hospital attendance.
Results: Patients receiving CPU assessment had significantly higher scores on the physical functioning (difference 5.1 points; 95% CI 1.1 to 9.0), vitality (4.6; 1.3 to 8.0), and general health (5.7; 2.3 to 9.2) dimensions of the SF-36 at two days, and significantly higher scores on all except the emotional role dimension at one month. They also had significantly lower depression scores on the HADS depression scale at two days (0.93; 0.34 to 1.51) and one month (1.0; 0.36 to 1.66). However, initially lower anxiety scores at two days (0.89; 0.21 to 1.56) were not maintained at one month (0.48; -0.26 to 1.23). CPU assessment was associated with reduced prevalence (OR 0.71; 95% CI 0.52 to 0.97) and severity (6.5 mm on 100 m visual analogue scale; 95% CI 2.2 to 10.8) of chest pain at one month, but no significant difference in the proportion of patients taking time off work (OR 0.82; 95% CI 0.54 to 1.04).
Conclusion: CPU assessment is associated with improvements in nearly all dimensions of quality of life and with reduced symptoms of depression.
- References:
J Accid Emerg Med. 2000 Jan;17(1):1-6. (PMID: 10658981)
Aust N Z J Psychiatry. 1998 Apr;32(2):172-9. (PMID: 9588295)
Health Technol Assess. 1999;3(5):iii-92. (PMID: 10982317)
Ann Emerg Med. 2001 Oct;38(4):369-76. (PMID: 11574792)
Emerg Med J. 2002 Mar;19(2):117-21. (PMID: 11904256)
BMJ. 2002 Jul 20;325(7356):116-7. (PMID: 12130592)
Emerg Med J. 2003 Sep;20(5):429-33. (PMID: 12954681)
BMJ. 2004 Jan 31;328(7434):254. (PMID: 14724129)
Acad Emerg Med. 2004 Aug;11(8):827-33. (PMID: 15289187)
Ann Intern Med. 1981 Dec;95(6):680-5. (PMID: 7305144)
Acta Psychiatr Scand. 1983 Jun;67(6):361-70. (PMID: 6880820)
Q J Med. 1987 Apr;63(240):315-22. (PMID: 3685244)
Int J Psychiatry Med. 1988;18(4):315-23. (PMID: 3235278)
J Intern Med. 1992 Jan;231(1):59-65. (PMID: 1732400)
J Gen Intern Med. 1993 May;8(5):231-5. (PMID: 8505680)
Can J Cardiol. 1994 Oct;10(8):827-34. (PMID: 7954018)
Am J Med. 1996 Oct;101(4):371-80. (PMID: 8873507)
Ann Emerg Med. 1997 Jan;29(1):109-15. (PMID: 8998089)
JAMA. 1997 Nov 26;278(20):1670-6. (PMID: 9388086)
BMJ. 2000 Jun 24;320(7251):1702-5. (PMID: 10864545)
- Molecular Sequence:
ISRCTN ISRCTN85078221
- الموضوع:
Date Created: 20040731 Date Completed: 20040923 Latest Revision: 20191210
- الموضوع:
20231215
- الرقم المعرف:
PMC509284
- الرقم المعرف:
10.1186/1477-7525-2-39
- الرقم المعرف:
15283863
No Comments.